Crossmark

Pre-emptive increase in the filgrastim dose based on the CD34+ cell count on day four of autologous stem cell mobilization

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.05.016

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chaves Utsch, Paulla Rayane https://orcid.org/0000-0002-4152-1879
Duarte, Fernando Barroso

Hallack Neto, Abrahão Elias https://orcid.org/0000-0001-6671-9710
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-09-13
More Information

This article is maintained by: Elsevier

Article Title: Pre-emptive increase in the filgrastim dose based on the CD34+ cell count on day four of autologous stem cell mobilization

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.05.016

Content Type: simple-article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.